Fred Hutch8h
Tricking cells into trashing cancer
In a study published today in the Journal of Clinical Investigation, Fred Hutch Cancer Center cancer chemical biologist ...
Medscape1mon
First-line Treatment of Advanced Ovarian Cancer: Current Research and Perspectives
Deeper knowledge of the biology of ovarian cancer has led to the identification of multiple molecular targets, such as growth factor receptors, signal transduction pathways, cell cycle regulators ...
Scientific American2y
Illuminate and Eliminate: A New Path to Stopping Ovarian Cancer
During this project, the researchers took a mouse monoclonal antibody called ... inoculated with commercially available ovarian cancer cell lines, and a second that had been inoculated with ...
Targeted Oncology10d
Novel CAR T-Cell Therapy Trial Advances to Third Cohort in Ovarian Cancer
A phase 1 trial evaluating FSHR-targeting CAR T cells for patients with ovarian cancer has dosed the first patient in its ...
manilatimes2mon
CERo Therapeutics, Inc. Presents Preclinical Data Demonstrating CER-1236 Killing Ovarian Cancer Cell Lines Without Toxicity
SOUTH SAN FRANCISCO, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) ("CERo”), an innovative immunotherapy company seeking to advance the next generation of ...
Yahoo Finance1mon
Ensem Therapeutics To Present Preclinical Data for Potential Best-in-Class Oral CDK2 Inhibitor at San Antonio Breast Cancer Symposium
In mouse xenograft studies using a CCNE-amplified ovarian cancer cell line or patient-derived tumors, ETX-197/BG-68501 showed sustained target engagement, dose-dependent tumor growth inhibition ...